Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-07-02

Clinical Trial Update: Preservative-free Tafluprost Eye Drops in Newly Diagnosed Patients With Glaucoma [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/3 trial updates on preservative-free tafluprost eye drops for newly diagnosed glaucoma patients have been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • tafLuprost eye drops (preservative-free) (tafluprost)

Snippet

Sponsor: Alexandria University | Conditions: Glaucoma | Phase 2, Phase 3 | Status: COMPLETED